Affinity biomimetic chromatography and its applications for antibody purification

doi:10.11949/j.issn.0438-1157.20160203

Abstract

Abstract:

Affinity biomimetic chromatography is a novel bioseparation technology for the biological active substance, particularly showing good performance for antibody purification with the advantages of low cost, stable ligand structure, high specificity and so on. The critical point of affinity biomimetic chromatography is the specially-designed biomimetic ligand. The biomimetic ligands used currently include chemical synthetic ligand and short peptide ligand, which are normally obtained by rational design and screening. For a particular target protein, instead of selecting the ligand randomly, it is necessary to build a reasonable ligand library by rational designing method and screen the suitable mimetic ligand by high-throughput screening technology. According to the recent advances in affinity biomimetic chromatography, the designing and screening of ligands used for affinity mimetic chromatography and the applications in antibody purification are reviewed in the present article.

null

Key words: affinity biomimetic chromatography, chemical synthetic ligand, short peptide ligand, antibody, purification, molecular simulation

摘要：

亲和仿生层析是一种新型的生物分离技术，可用于生物活性物质分离，尤其在抗体纯化中表现出良好的应用前景，具有价格低廉、结构稳定、特异性较高等优点。亲和仿生层析的核心是具有特定结构的仿生配基，主要包括化学合成配基和短肽配基两种，通常通过合理的手段进行筛选和设计。理性设计是一种行之有效的方法，针对一个特定的目标蛋白，随机地去选择配基是不可能的，必须采用理性设计构建一个合理的配基库，并通过高通量的筛选技术，才能得到合适的仿生配基。本文根据近年来国内外亲和仿生层析的研究进展，着重介绍了亲和仿生配基的筛选和设计以及在抗体纯化中的应用。

关键词: 亲和仿生层析, 化学合成配基, 短肽配基, 抗体, 纯化, 分子模拟

CLC Number:

TQ028

LU Huili, LIN Dongqiang, YAO Shanjing. Affinity biomimetic chromatography and its applications for antibody purification[J]. CIESC Journal, 2016, 67(9): 3523-3535.

卢慧丽, 林东强, 姚善泾. 亲和仿生层析及在抗体纯化中的应用[J]. 化工学报, 2016, 67(9): 3523-3535.

References 80

[1]	SERPA G, AUGUSTO E F P, TAMASHIRO W M S C, et al. Evaluation of immobilized metal membrane affinity chromatography for purification of an immunoglobulin G1 monoclonal antibody[J]. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences, 2005, 816(1/2):259-268.
[2]	ZIMMERMAN T, FRERE C P, SATZGER M, et al. Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments[J]. Journal of Immunological Methods, 2006, 314(1/2):67-73.
[3]	LOWE C R,PEARSON J C. Affinity chromatography on immobilized dyes[J]. Methods in Enzymology, 1984, 104(104):97-113.
[4]	CLONIS Y D, LABROU N E, KOTSIRA V P, et al. Biomimetic dyes as affinity chromatography tools in enzyme purification[J]. Journal of Chromatography A, 2000, 891(1):33-44.
[5]	童红飞. 新型疏水性电荷诱导配基设计及层析分离抗体研究[D]. 杭州:浙江大学, 2014:18-22. TONG H F. Antibody separation by hydrophobic charge-induction chromatography and novel ligand design[D]. Hangzhou:Zhejiang University, 2014:18-22.
[6]	MURAD J P, LIN O A, PAEZ ESPINOSA E V, et al. Current and experimental antibody-based therapeutics:insights, breakthroughs, setbacks and future directions[J]. Current Molecular Medicine, 2013, 13(1):165-178.
[7]	SHUKLA A A, HUBBARD B, TRESSEL T, et al. Downstream processing of monoclonal antibodies-application of platform approaches[J]. Journal of Chromatography B, 2007, 848(1):28-39.
[8]	LOW D, O'LEARY R,PUJAR N S. Future of antibody purification[J]. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences, 2007, 848(1):48-63.
[9]	ROQUE A C, SILVA C S,TAIPA M Â. Affinity-based methodologies and ligands for antibody purification:advances and perspectives[J]. Journal of Chromatography A, 2007, 1160(1):44-55.
[10]	SU F T, SPROULE K, HUSAIN A, et al. Affinity chromatography on immobilized "biomimetic" ligands. Synthesis, immobilization and chromatographic assessment of an immunoglobulin G-binding ligand[J]. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences, 2000, 740(1):1-15.
[11]	ROQUE A C A, ÂNGELA T M,LOWE C R. Synthesis and screening of a rationally designed combinatorial library of affinity ligands mimicking protein L from Peptostreptococcus magnus[J]. Journal of Molecular Recognition, 2005, 18(3):213-224.
[12]	ROQUE A C A, TAIPA M Â,LOWE C R. An artificial protein L for the purification of immunoglobulins and Fab fragments by affinity chromatography[J]. Journal of Chromatography A, 2005, 1064(2):157-167.
[13]	LI R, DOWD V, STEWART D J, et al. Design, synthesis, and application of a protein A mimetic[J]. Nature Biotechnology, 1998, 16(2):190-195.
[14]	KHOURY G E, WANG Y, WANG D, et al. Design, synthesis, and assessment of a de novo affinity adsorbent for the purification of recombinant human erythropoietin[J]. Biotechnology & Bioengineering, 2013, 110(11):3063-3069.
[15]	HAIGH J M, HUSSAIN A, MIMMACK M L, et al. Affinity ligands for immunoglobulins based on the multicomponent Ugi reaction[J]. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences, 2009, 877(14/15):1440-1452.
[16]	TENG S F, SPROULE K, HUSSAIN A, et al. A strategy for the generation of biomimetic ligands for affinity chromatography. Combinatorial synthesis and biological evaluation of an IgG binding ligand[J]. Journal of Molecular Recognition, 1999, 12(1):67-75.
[17]	ALEXER D,IVAR U. Multicomponent reactions with isocyanides[J]. Angewandte Chemie, 2000, 39(18):3168-3210.
[18]	RALD P G, PATRICK S,EGISTO B. The quest for affinity chromatography ligands:are the molecular libraries the right source?[J]. Journal of Separation Science, 2015, 38(15) 2559-2572.
[19]	DOMLING A. Recent developments in isocyanide based multicomponent reactions in applied chemistry[J]. Chemical Reviews, 2006, 106(1):17-89.
[20]	WEBER L, ILLGEN K,ALMSTETTER M. Discovery of new multi component reactions with combinatorial methods[J]. Synlett, 1999, 1999(3):366-374.
[21]	YANG H, GURGEL P V,CARBONELL R G. Purification of human immunoglobulin G via Fc-specific small peptide ligand affinity chromatography[J]. Journal of Chromatography A, 2009, 1216(6):910-918.
[22]	YANG H, GURGEL P V, WILLIAMS D K, et al. Binding site on human immunoglobulin G for the affinity ligand HWRGWV[J]. Journal of Molecular Recognition, 2010, 23(3):271-282.
[23]	NAIK A D, MENEGATTI S, GURGEL P V, et al. Performance of hexamer peptide ligands for affinity purification of immunoglobulin G from commercial cell culture media[J]. Journal of Chromatography A, 2011, 1218(13):1691-1700.
[24]	MENEGATTI S, NAIK A D, GURGEL P V, et al. Alkaline-stable peptide ligand affinity adsorbents for the purification of biomolecules[J]. Journal of Chromatography A, 2012, 1245(13):55-64.
[25]	GEYSEN H M, RODDA S J,MASON T J. A priori delineation of a peptide which mimics a discontinuous antigenic determinant[J]. Molecular Immunology, 1986, 23(7):709-715.
[26]	任军,贾凌云. 亲和色谱仿生配基的筛选和设计[J]. 分析化学, 2005, 33(9):1345-1349. REN J, JIA L Y. Screening and design of affinity chromatography biomimetic ligand[J]. Chinese Journal of Analytical Chemistry, 2005, 33(9):1345-1349.
[27]	PLATIS D, MALTEZOS A, MA K C, et al. Combinatorial de novo design and application of a biomimetic affinity ligand for the purification of human anti-HIV mAb 4E10 from transgenic tobacco[J]. Journal of Molecular Recognition, 2009, 22(6):415-424.
[28]	ANASTASIOS M, DIMITRIS P, DIMITRIOS V, et al. Design, synthesis and application of benzyl-sulfonate biomimetic affinity adsorbents for monoclonal antibody purification from transgenic corn[J]. Journal of Molecular Recognition, 2014, 27(1):19-31.
[29]	QIAN J, KHOURY G E, ISSA H, et al. A synthetic protein G adsorbent based on the multi-component Ugi reaction for the purification of mammalian immunoglobulins[J]. Journal of Chromatography B, 2012, 898(6):15-23.
[30]	KHOURY G E, LOWE C R. A biomimetic protein G affinity adsorbent:an Ugi ligand for immunoglobulins and Fab fragments based on the third IgG-binding domain of protein G[J]. Journal of Molecular Recognition, 2013, 26(4):190-200.
[31]	SALVALAGLIO M, ZAMOLO L, BUSINI V, et al. Molecular modeling of protein A affinity chromatography[J]. Journal of Chromatography A, 2009, 1216(50):8678-8686.
[32]	HUANG B, LIU F F, DONG X Y, et al. Molecular mechanism of the affinity interactions between protein A and human immunoglobulin G1 revealed by molecular simulations[J]. Journal of Physical Chemistry B, 2011, 115(14):4168-4176.
[33]	ZHAO W W, LIU F F, SHI Q H, et al. Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex[J]. Biochemical Engineering Journal, 2014, 88(28):1-11.
[34]	TONG H F, LIN D Q, ZHANG Q L, et al. Molecular recognition of Fc-specific ligands binding onto the consensus binding site of IgG:insights from molecular simulation[J]. Journal of Molecular Recognition, 2014, 27(8):501-509.
[35]	TONG H F, LIN D Q, CHU W N, et al. Multimodal charge-induction chromatography for antibody purification[J]. Journal of Chromatography A, 2015, 1429:258-264.
[36]	WANG R Z, LIN D Q, TONG H F, et al. Molecular insights into the binding selectivity of a synthetic ligand DAAG to Fc fragment of IgG[J]. Journal of Molecular Recognition, 2014, 27(5):250-259.
[37]	SPROULE K, MORRILL P, PEARSON J C, et al. New strategy for the design of ligands for the purification of pharmaceutical proteins by affinity chromatography[J]. Journal of Chromatography B Biomedical Sciences & Applications, 2000, 740(1):17-33.
[38]	BAUMANN H, ÖHRMAN S, SHINOHARA Y, et al. Rational design, synthesis, and verification of affinity ligands to a protein surface cleft[J]. Protein Science A Publication of the Protein Society, 2003, 12(4):784-793.
[39]	CARREDANO E, BAUMANN H, GR NBERG A, et al. A novel and conserved pocket of human κ-Fab fragments:design, synthesis, and verification of directed affinity ligands[J]. Protein Science, 2004, 13(6):1476-1488.
[40]	LIU F F, DONG X Y, WANG T, et al. Rational design of peptide ligand for affinity chromatography of tissue-type plasminogen activator by the combination of docking and molecular dynamics simulations[J]. Journal of Chromatography A, 2007, 1175(2):249-258.
[41]	王荣柱. 以四肽为配基的仿生层析和抗体的分离纯化[D]. 杭州:浙江大学, 2015:14-18. WANG R Z. Research on tetrapeptide biomimetic chromatography for antibody purification[D]. Hangzhou:Zhejiang University, 2015:14-18.
[42]	SARASWAT L D, ZHANG H, HARDY L W, et al. Affinity ligand selection from a library of small molecules:assay development, screening, and application[J]. Biotechnology Progress, 2005, 21(1):300-308.
[43]	LAM K S, SALMON S E, HERSH E M, et al. A new type of synthetic peptide library for identifying ligand-binding activity[J]. Nature, 1991, 354(6348):82-84.
[44]	LAM K S, WADE S, ABDULLATIF F, et al. Application of a dual-color detection scheme in the screening of a random combinatorial peptide library[J]. Journal of Immunological Methods, 1995, 180(2):219-223.
[45]	BUETTNER J A, DADD C A, BAUMBACH G A, et al. Chemically derived peptide libraries:a new resin and methodology for lead identification[J]. International Journal of Peptide and Protein Research, 1996, 47(1/2):70-83.
[46]	KAUFMAN D B, HENTSCH M E, BAUMBACH G A, et al. Affinity purification of fibrinogen using a ligand from a peptide library[J]. Biotechnology & Bioengineering, 2002, 77(3):278-289.
[47]	GURGEL P V, CARBONELL R G,SWAISGOOD H E. Identification of peptide ligands generated by combinatorial chemistry that bind α-lactalbumin[J]. Separation Science & Technology, 2001, 36(11):2411-2431.
[48]	GURGEL P V, CARBONELL R G,SWAISGOOD H E. Fractionation of whey proteins with a hexapeptide ligand affinity resin[J]. Bioseparation, 2000, 9(6):385-392.
[49]	YANG H, GURGEL P V,CARBONELL R G. Hexamer peptide affinity resins that bind the Fc region of human immunoglobulin G[J]. Journal of Peptide Research, 2005, 66(s1):120-137.
[50]	NAIK A D, MENEGATTI S, REESE H R, et al. Process for purification of monoclonal antibody expressed in transgenic Lemna plant extract using dextran-coated charcoal and hexamer peptide affinity resin[J]. Journal of Chromatography A, 2012, 1260(20):61-66.
[51]	BILLAKANTI J M, FEE C J, NAIK A D, et al. Application of peptide chromatography for the isolation of antibodies from bovine skim milk, acid whey and colostrum[J]. Food & Bioproducts Processing, 2014, 92(2):199-207.
[52]	黄波. 抗体亲和肽配基的理性设计和色谱表征[D]. 天津:天津大学, 2011:4-18. HUANG B. Rational design of affinity peptide ligands for antibody and chromatographic characterizations[D]. Tianjin:Tianjin University, 2011:4-18
[53]	CWIRLA S E, PETERS E A, BARRETT R W, et al. Peptides on phage:a vast library of peptides for identifying ligands[J]. Proceedings of the National Academy of Sciences of the United States of America, 1990, 87(16):6378-6382.
[54]	HUANG P Y, BAUMBACH G A, DADD C A, et al. Affinity purification of von Willebrand factor using ligands derived from peptide libraries[J]. Bioorganic & Medicinal Chemistry, 1996, 4(5):699-708.
[55]	GASKIN D, STARCK K, TURNER N A, et al. Phage display combinatorial libraries of short peptides:ligand selection for protein purification[J]. Enzyme & Microbial Technology, 2001, 28(9/10):766-772.
[56]	EHRLICH G K, BAILON P. Identification of model peptides as affinity ligands for the purification of humanized monoclonal antibodies by means of phage display[J]. Journal of Biochemical & Biophysical Methods, 2001, 49(1/2/3):443-454.
[57]	FENG H Q, JIA L Y, LI H L, et al. Screening and chromatographic assessing of a novel IgG biomimetic ligand[J]. Biomedical Chromatography, 2006, 20(10):1109-1115.
[58]	LIU F F, WANG T, DONG X Y, et al. Rational design of affinity peptide ligand by flexible docking simulation[J]. Journal of Chromatography A, 2007, 1146(1):41-50.
[59]	AGHAEE E, GHASEMI J B, MANOUCHEHRI F, et al. Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin[J]. Journal of Molecular Modeling, 2014, 20(10):1-13.
[60]	GHOSE S, HUBBARD B,CRAMER S M. Evaluation and comparison of alternatives to protein A chromatography mimetic and hydrophobic charge induction chromatographic stationary phases[J]. Journal of Chromatography A, 2006, 1122(1/2):144-152.
[61]	CHHATRE S, FRANCIS R, TITCHENER-HOOKER N J, et al. Evaluation of a novel agarose-based synthetic ligand adsorbent for the recovery of antibodies from ovine serum[J]. Journal of Chromatography B Analytical Technologies in the Biomedical & Life Sciences, 2007, 860(2):209-217.
[62]	ZAMOLO L, SALVALAGLIO M, CAVALLOTTI C, et al. Experimental and theoretical investigation of effect of spacer arm and support matrix of synthetic affinity chromatographic materials for the purification of monoclonal antibodies[J]. Journal of Physical Chemistry B, 2010, 114(29):9367-9380.
[63]	KABIR S. Immunoglobulin purification by affinity chromatography using protein A mimetic ligands prepared by combinatorial chemical synthesis[J]. Immunological Investigations, 2002, 31(3/4):263-278.
[64]	BRANCO R J F, DIAS A M G C,ROQUE A C A. Understanding the molecular recognition between antibody fragments and protein A biomimetic ligand[J]. Journal of Chromatography A, 2012, 1244(12):106-115.
[65]	SANTANA S D F, DHADGE V L,ROQUE A C A. Dextran-coated magnetic supports modified with a biomimetic ligand for IgG purification[J]. ACS Applied Materials & Interfaces, 2012, 4(11):5907-5914.
[66]	PADILLA S, ALVAREZ T, FERRO W, et al. Assessment of synthetic protein-A mabsorbents in antibody purification from tobacco plant extract[J]. Chromatographia, 2010, 72(1/2):121-125.
[67]	BARROSO T, LOUREN O A, ARA JO M, et al. A green approach toward antibody purification:a sustainable biomimetic ligand for direct immobilization on (bio)polymeric supports[J]. Journal of Molecular Recognition, 2013, 26(12):662-671.
[68]	BARROSO T, BRANCO R J F, AGUIAR-RICARDO A, et al. Structural evaluation of an alternative protein A biomimetic ligand for antibody purification[J]. Journal of Computer-Aided Molecular Design, 2014, 28(1):25-34.
[69]	FASSINA G, VERDOLIVA A, ODIERNA M R, et al. Protein A mimetic peptide ligand for affinity purification of antibodies[J]. Journal of Molecular Recognition, 1996, 9(5/6):564-569.
[70]	FASSINA G, RUVO M, PALOMBO G, et al. Novel ligands for the affinity-chromatographic purification of antibodies[J]. Journal of Biochemical & Biophysical Methods, 2001, 49(1/2/3):481-490.
[71]	FASSINA G, VERDOLIVA A, PALOMBO G, et al. Immunoglobulin specificity of TG19318:a novel synthetic ligand for antibody affinity purification[J]. Journal of Molecular Recognition, 1998, 11(1-6):128-133.
[72]	PALOMBO G, FALCO S D, TORTORA M, et al. A synthetic ligand for IgA affinity purification[J]. Journal of Molecular Recognition, 1998, 11(1-6):243-246.
[73]	PALOMBO G, ROSSI M, CASSANI G, et al. Affinity purification of mouse monoclonal IgG using a protein A mimetic ligand (TG19318) immobilized on solid supports[J]. Journal of Molecular Recognition, 1998, 11(1-6):247-249.
[74]	PALOMBO G, VERDOLIVA A,FASSINA G. Affinity purification of immunoglobulin M using a novel synthetic ligand[J]. Journal of Chromatography B Biomedical Sciences & Applications, 1998, 715(1):137-145.
[75]	VERDOLIVA A, PANNONE F, ROSSI M, et al. Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand:comparison with protein A and protein G[J]. Journal of Immunological Methods, 2002, 271(271):77-88.
[76]	SUGITA T, KATAYAMA M, OKOCHI M, et al. Screening of peptide ligands that bind to the Fc region of IgG using peptide array and its application to affinity purification of antibody[J]. Biochemical Engineering Journal, 2013, 79(2):33-40.
[77]	ZHAO W W, LIU F F, SHI Q H, et al. Octapeptide-based affinity chromatography of human immunoglobulin G:comparisons of three different ligands[J]. Journal of Chromatography A, 2014, 1359:100-111.
[78]	ZHAO W W, SHI Q H,YAN S. Fywhclde-based affinity chromatography of IgG:effect of ligand density and purifications of human IgG and monoclonal antibody[J]. Journal of Chromatography A, 2014, 1355:107-114.
[79]	ZHAO W W, SHI Q H,YAN S. Dual-ligand affinity systems with octapeptide ligands for affinity chromatography of hIgG and monoclonal antibody[J]. Journal of Chromatography A, 2014, 1369:64-72.
[80]	STEFANO M, MAHMUD H, AMITH D N, et al. mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands[J]. Biotechnology & Bioengineering, 2013, 110(3):857-870.